"Strength in cancer care, grounded in faith. Our Cancer Center is here when you need care for any type of cancer, including breast, prostate and lung cancer. Schedule a consultation with one of our oncologists today — we’re open and safe during COVID-19. Our skilled cancer experts provide compassionate care tailored to your needs. You have access to comprehensive cancer services, including diagnosis, treatment, ongoing care and support resources. No matter what you need help with, we’re here to serve."

During the past decade, Loma Linda University Cancer Institute at Loma Linda University Medical Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 43 clinical trials were completed, i.e. on average, 238.9% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Loma Linda University Cancer Institute at Loma Linda University Medical Center" #1 sponsor was "Children's Oncology Group" with 34 trials, followed by "Bristol-Myers Squibb" with 9 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored, "Radiation Therapy Oncology Group" with 7 trials sponsored and "Loma Linda University" with 7 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loma Linda University Cancer Institute at Loma Linda University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Children's Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Loma Linda University Cancer Institute at Loma Linda University Medical Center" are "Breast Cancer" (14 trials), "Leukemia" (10 trials), "Sarcoma" (7 trials), "Lymphoma" (6 trials) and "Prostate Cancer" (6 trials). Many other conditions were trialed in "Loma Linda University Cancer Institute at Loma Linda University Medical Center" in a lesser frequency.

Most popular intervention types in "Loma Linda University Cancer Institute at Loma Linda University Medical Center" are "Drug" (96 trials), "Radiation" (27 trials), "Procedure" (25 trials), "Biological" (23 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (25 trials), "radiation therapy" (23 trials), "etoposide" (17 trials), "vincristine sulfate" (15 trials) and "filgrastim" (13 trials). Other intervention names were less common.

The vast majority of trials in "Loma Linda University Cancer Institute at Loma Linda University Medical Center" are 87 trials for "All" genders, 18 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Loma Linda University Cancer Institute at Loma Linda University Medical Center". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Loma Linda University Cancer Institute at Loma Linda University Medical Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Loma Linda University Cancer Institute at Loma Linda University Medical Center, 7 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".